Fulcrum Therapeutics (FULC)
(Delayed Data from NSDQ)
$7.21 USD
-0.21 (-2.83%)
Updated May 24, 2024 04:00 PM ET
After-Market: $7.45 +0.24 (3.33%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $-0.06 | 0.00% |
Earnings Summary
For their last quarter, Fulcrum Therapeutics (FULC) reported earnings of -$0.43 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 2.27%. Look out for FULC's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.06 per share, reflecting a year-over-year increase of 84.21%.
Earnings History
Price & Consensus
Zacks News for FULC
Biotech Stock Roundup: NVAX, FULC Up on Deals With SNY, Updates From MRNA, BMY
FULC: What are Zacks experts saying now?
Zacks Private Portfolio Services